Current Assets
Total Current Assets
Bristol-Myers Squibb Total Current Assets decreased by 17.5% to $29.39B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.3%, from $29.78B to $29.39B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows relatively stable performance with a -0.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
A higher value relative to current liabilities indicates a strong safety margin for meeting short-term obligations.
Detailed definition
The sum of all assets that are reasonably expected to be converted into cash or consumed within one year. This aggregate...
Peer comparison
High-growth tech companies often maintain high current asset levels to support rapid scaling and R&D needs.
Metric ID:
total_current_assetsHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $29.16B | $31.44B | $33.26B | $30.12B | $30.19B | $26.80B | $27.27B | $27.09B | $28.07B | $27.63B | $31.77B | $28.67B | $26.89B | $28.08B | $29.78B | $30.78B | $33.22B | $35.63B | $29.39B |
| QoQ Change | — | +7.8% | +5.8% | -9.4% | +0.2% | -11.2% | +1.8% | -0.7% | +3.6% | -1.6% | +15.0% | -9.8% | -6.2% | +4.4% | +6.1% | +3.4% | +7.9% | +7.2% | -17.5% |
| YoY Change | — | — | — | — | +3.5% | -14.8% | -18.0% | -10.1% | -7.0% | +3.1% | +16.5% | +5.8% | -4.2% | +1.6% | -6.3% | +7.4% | +23.5% | +26.9% | -1.3% |
Range$26.80B – $35.63B
CAGR+0.2%
Avg YoY Growth+1.8%
Median YoY Growth+1.6%
Total Current Assets at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's total current assets?
- Bristol-Myers Squibb (BMY) reported total current assets of $29.39B in Q4 2025.
- How has Bristol-Myers Squibb's total current assets changed year-over-year?
- Bristol-Myers Squibb's total current assets decreased by 1.3% year-over-year, from $29.78B to $29.39B.
- What is the long-term trend for Bristol-Myers Squibb's total current assets?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's total current assets has grown at a -0.5% compound annual growth rate (CAGR), from $30.19B to $29.39B.
- What does total current assets mean?
- Everything the company owns that can be turned into cash within a single year.